peptide-based Nrf2-dependent ARE activators (InterMune)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namepeptide-based Nrf2-dependent ARE activators (InterMune)
Drug Alias NameITMN-12638ITMN-11146
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionantioxidantNuclear factor erythroid 2-related factor 2 stimulants
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIntermune Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntermune Inc
Active IndicationsN/A
Inactive IndicationsFibrosis

Other Information

ATC CodeN/A
Related LinksN/A